OTCMKTS:CHEOY Cochlear (CHEOY) Stock Price, News & Analysis $99.67 +0.11 (+0.11%) As of 01/31/2025 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesSEC FilingsShort Interest About Cochlear Stock (OTCMKTS:CHEOY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cochlear alerts:Sign Up Key Stats Today's Range$98.91▼$99.7450-Day Range$89.59▼$100.0652-Week Range$89.39▼$115.85Volume7,343 shsAverage Volume10,302 shsMarket Capitalization$13.04 billionP/E RatioN/ADividend Yield1.31%Price TargetN/AConsensus RatingHold Company OverviewCochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Read More… Receive CHEOY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address CHEOY Stock News HeadlinesCochlear Limited (CHEOF) Gets a Buy from RBC CapitalJanuary 31 at 12:02 AM | markets.businessinsider.comCochlear Limited Announces New Securities QuotationJanuary 29 at 9:21 PM | tipranks.comYou won’t believe where OpenAI billionaire is investing nowBillionaire Sam Altman has become one of the most powerful men in the world by running OpenAI… But there’s a far lesser known investment he’s making that could put OpenAI to shame. In fact this Sam Altman-backed company could actually become a crucial partner for OpenAI… And the US Military… not to mention hundreds of other giant companies around the globe. To make the story even crazier… this company only recently became viable, thanks to an obscure piece of legislation that President Trump signed before he left office… Which ordered the government to take this incredible new technology seriously.February 1, 2025 | Wealthpin Pro (Ad)Cochlear Implants Market to Reach US$ 3.0 Bn in Revenue by 2034, Driven by Aging Population and Cutting-Edge Innovations | Transparency Market ResearchJanuary 29 at 11:04 AM | globenewswire.comCochlear Ltd ADR CHEOYJanuary 28, 2025 | morningstar.comCochlear Limited Announces HY25 Financial Results BriefingJanuary 19, 2025 | tipranks.comJefferies Sticks to Its Hold Rating for Cochlear Limited (CHEOF)January 19, 2025 | markets.businessinsider.comCochlear Limited Issues New Unquoted Equity SecuritiesDecember 23, 2024 | markets.businessinsider.comSee More Headlines CHEOY Stock Analysis - Frequently Asked Questions How have CHEOY shares performed this year? Cochlear's stock was trading at $89.59 at the start of the year. Since then, CHEOY stock has increased by 11.3% and is now trading at $99.67. View the best growth stocks for 2025 here. How do I buy shares of Cochlear? Shares of CHEOY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today2/01/2025Next Earnings (Estimated)2/13/2025Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Holding & other investment offices Sub-IndustryN/A Current SymbolOTCMKTS:CHEOY Previous SymbolOTCMKTS:CHEOY CUSIPN/A CIK1453930 Webwww.cochlear.com Phone(129) 428-6555FaxN/AEmployees5,155Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio2.30 Quick Ratio1.68 Sales & Book Value Annual Sales$1.49 billion Price / Sales8.76 Cash Flow$2.39 per share Price / Cash Flow41.64 Book Value$9.21 per share Price / Book10.82Miscellaneous Outstanding Shares130,860,000Free FloatN/AMarket Cap$13.04 billion OptionableNot Optionable Beta0.93 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (OTCMKTS:CHEOY) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump loves DeepSeekPresident Trump could be ecstatic. And it's all thanks to DeepSeek. The secretive Chinese startup just r...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredNew catalyst on Wall Street’s radar for this week (NOT Trump)Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger ...Timothy Sykes | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cochlear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
